20-F/AAMENDMENTNYMXFCIK 0001018735

NYMOX PHARMACEUTICAL CORP

Name: SEC EDGAR filing 0001640334-26-001603
Creator: NYMOX PHARMACEUTICAL CORP
License: https://www.usa.gov/government-works

Foreign annual (20-F/A) filed September 29, 2026.

Annual report filed by foreign private issuers listed on U.S. exchanges.

Open the filing on SEC.gov

New to the 20-F/A? What it is and how to read one

Filing facts

Accession number: 0001640334-26-001603
Filer: NYMOX PHARMACEUTICAL CORP
Ticker: NYMXF
CIK: 0001018735
Form type: 20-F/A
Form description: Foreign annual
Filed at: September 29, 2026
Industry: SIC 2835In Vitro & In Vivo Diagnostic Substances
Last verified: September 30, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1018735/000164033426001603/0001640334-26-001603-index.htm ↗

Filer's full EDGAR submission history

EDGAR · NYMOX PHARMACEUTICAL CORP (0001018735) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001640334-26-001603.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.